STEMSOFT® Software Inc. Launches Certified Partner Program STEMSOFT Software Inc. announced the launch of a new Certified Partner Program. This new program is designed to help STEMSOFT clients identify complementary products or services that will be of benefit to them and ultimately assist them with finding the answers to the questions or unique need they have. [STEMSOFT Software Inc. Press Release]
Innovative Therapy Method for the Treatment of Brain Tumors The Fraunhofer Institute for Cell Therapy and Immunology IZI and Northwest Biotherapeutics Inc. are cooperating in the development of production processes and establishment of an innovative therapy method for the treatment of glioblastomas in Europe. [Fraunhofer Institute for Cell Therapy and Immunology IZI Press Release] Monash Leads Australia-India Research Collaboration Monash projects have been awarded almost a quarter of the $5 million in available funding through Round 5 of the Australia-India Strategic Research Fund. [Monash University Press Release] Coulter Foundation and Stanford Establish $20 Million Endowment for Bioengineering Projects to Fill Medical Needs A $20 million endowment to support the translation of ideas that address unmet medical needs into treatments and devices that improve human health has been established in the Stanford University Department of Bioengineering, with support from the Wallace H. Coulter Foundation and the university. [Stanford University School of Medicine Press Release] Kerecis Completes Interim Financing Kerecis Limited has secured US$ 1 million in interim financing. The US$ 1 million financing is a mixture of equity, grants and debt and is provided by a group of existing and new stakeholders. [Kerecis Limited Press Release] Prima BioMed Completes $21 Million Placement Prima BioMed Ltd. announced that it has successfully completed the placement of new ordinary shares that was announced on Wednesday 25 May 2011. [Prima BioMed Ltd. Press Release] Maryland Stem Cell Research Commission Funds 36 New Projects in FY 2011 The Maryland Stem Cell Research Commission has completed its review of the 180 applications received in response to its three FY 2011 Requests for Applications. [Maryland Stem Cell Research Fund Press Release]
Nationwide Children’s Hospital Researchers Receives NIH Grant for the Move Toward Clinical Trials Targeting the Lysosomal Storage Disease MPSIIIB Investigators at Nationwide Children’s have received a grant from the National Institutes of Health (NIH) to help move a therapy for MPS IIIB that has been shown effective in mice toward clinical trials in humans. [Nationwide Children’s Hospital Press Release] Four B.C. Cancer Researchers Receive Nearly $2 Million in Grants Dr. Raymond Andersen is among four B.C. researchers to receive nearly $2 million from the Canadian Cancer Society. [Vancouver Sun] UK’s NICE Backs Roche Drug as Maintenance Therapy Roche’s cancer drug MabThera has been recommended for use on Britain’s state health service as a maintenance therapy for patients with follicular non-Hodgkin’s lymphoma, expanding the market for the medicine. [Reuters]
OncoSec Medical to Initiate Multiple Phase II Skin Cancer Clinical Trials OncoSec Medical Incorporated announced it will initiate three Phase II clinical trials to assess its cancer-destroying, tissue-sparing ElectroImmunotherapy technology in patients with melanoma, Merkel cell carcinoma and cutaneous T-cell lymphoma. [PR Newswire]
Adaptimmune Announces Opening of Phase I/II Clinical Trial in Multiple Myeloma Adaptimmune announced that it has opened a Phase I/II, dual site, two‐cohort, open‐label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy. [Adaptimmune Ltd. Press Release] TxCell Receives Approval for Extension of Phase I/II Clinical Trial in Crohn’s Disease TxCell SA announces the approval by AFSSAPS, the French regulatory agency, of its application to extend treatment of patients included in the Crohn’s Disease Phase I/II study with Ovasave, a type 1 regulatory T cell based immunotherapy. [TxCell SA Press Release] Notification of Date of Preliminary Results and Update on Stroke Clinical Trial ReNeuron Group plc announced the completion of dosing of the first cohort of patients in the PISCES clinical trial of its ReN001 stem cell therapy for disabled stroke patients. [ReNeuron Group plc Press Release]
Patrick Hwu, M.D., and Mario Sznol, M.D., Join Genesis Biopharma’s Scientific and Medical Advisory Board Genesis Biopharma, Inc. announced that Patrick Hwu, M.D., and Mario Sznol, M.D., have joined the Company’s recently formed Scientific and Medical Advisory Board. [Genesis Biopharma, Inc. Press Release]
Christopher Kane, M.D., Appointed C. Lowell & JoEllen Parsons Endowed Chair Christopher Kane, M.D., has been named the inaugural holder of the C. Lowell and JoEllen Parsons Endowed Chair in Urology. [University of California, San Diego Press Release] David Nassif Joins Histogen as President and CFO Histogen, Inc. announced that David Nassif, J.D. has joined the Company as President and Chief Financial Officer. [Histogen, Inc. Press Release] UCSF School of Medicine Names Vice Dean of Education Catherine Reinis Lucey, M.D., has been appointed vice dean for education in the University of California, San Francisco (UCSF) School of Medicine. [University of California, San Francisco Press Release]
Flotte Elected to ASGCT Advisory Council Terence R. Flotte, M.D. has been elected to a five-year term on the Advisory Council of the American Society of Gene & Cell Therapy (ASGCT). [University of Massachusetts Medical School Press Release]
Nobel Laureate Receives Porter Prize from Pitt’s Graduate School of Public Health Françoise Barré-Sinoussi, Ph.D. is the 2011 recipient of the University of Pittsburgh Graduate School of Public Health’s Porter Prize in recognition of her outstanding achievements promoting health and preventing disease through her many contributions to HIV/AIDS research. [University of Pittsburgh Medical Center Press Release] Alvarez-Buylla Recognized for Pioneering Stem Cell Research Neural stem cell scientist Arturo Alvarez-Buylla, Ph.D. received word that he was one of three scientists named to receive the 2011 Prince of Asturias Award for Technical and Scientific Research. [University of California, San Francisco Press Release] ISSCR Awards Announced for Innovation, Public Service and Outstanding Young Investigator Three key awards – the International Society for Stem Cell Research (ISSCR) McEwen Centre Award for Innovation, the ISSCR Public Service Award and the Outstanding Young Investigator Award – will be presented at the 9th Annual Meeting of the International Society for Stem Cell Research. [International Society for Stem Cell Research Press Release] Lee W. Wattenberg, M.D., Receives the 2011 AACR Award for Lifetime Achievement in Cancer Prevention Research Lee W. Wattenberg, M.D., will receive the 2011 American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Prevention Research for his role in launching the field of chemoprevention and his work to understand the potential mechanisms of action of chemopreventive compounds. [American Association for Cancer Research Press Release] Salk Gift Dedicates Two Endowed Chairs – in Honor of Nobel Prize Winners and Past Presidents The Salk Institute for Biological Studies announced the visionary gift of Irwin and Joan Jacobs in the dedication of two endowed chairs to pay permanent tribute to Drs. Dulbecco and Guillemin. [Salk Institute for Biological Studies Press Release] |